Yan Zhao - Bloomage Biotechnology Chairman GM
| 688363 Stock | 59.16 1.32 2.28% |
Chairman
Yan Zhao is Chairman GM of Bloomage Biotechnology Corp
| Age | 58 |
| Address | Tech Development Zone, Jinan, China, 250101 |
| Phone | 86 531 8268 5998 |
| Web | https://www.bloomagebioactive.com |
Bloomage Biotechnology Management Efficiency
The company has return on total asset (ROA) of 0.0319 % which means that it generated a profit of $0.0319 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.062 %, meaning that it generated $0.062 on every $100 dollars invested by stockholders. Bloomage Biotechnology's management efficiency ratios could be used to measure how well Bloomage Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Bloomage Biotechnology's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 5.6 B, whereas Net Tangible Assets are forecasted to decline to about 3.4 B.Similar Executives
| Found 3 records | CHAIRMAN Age | ||
| Wenhui Lv | AVCON Information Tech | 46 | |
| Wenhui Lu | AVCON Information Tech | 46 | |
| Yu Wang | Guangzhou Ruoyuchen Information | 39 | |
Management Performance
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 |
Bloomage Biotechnology Leadership Team
Elected by the shareholders, the Bloomage Biotechnology's board of directors comprises two types of representatives: Bloomage Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bloomage. The board's role is to monitor Bloomage Biotechnology's management team and ensure that shareholders' interests are well served. Bloomage Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bloomage Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lingli Lin, Deputy Director | ||
| Hui Wang, CFO Director | ||
| Guixin Xu, Deputy Manager | ||
| Gao Yi, Deputy Manager | ||
| Xueping Guo, Deputy Director | ||
| Aihua Wang, Ex Director | ||
| Yihong Luan, Deputy Technician | ||
| Yan Zhao, Chairman GM | ||
| Tao Tian, Head Supervisor | ||
| Luan Yizheng, Deputy Officer | ||
| Jiajun Guo, Deputy Director | ||
| Aihua Liu, Deputy Director | ||
| Yizheng Li, Secretary GM |
Bloomage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bloomage Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.062 | ||||
| Return On Asset | 0.0319 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 27.62 B | ||||
| Shares Outstanding | 481.68 M | ||||
| Shares Owned By Insiders | 61.00 % | ||||
| Shares Owned By Institutions | 16.57 % | ||||
| Price To Book | 3.97 X | ||||
| Price To Sales | 4.96 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Bloomage Stock
Bloomage Biotechnology financial ratios help investors to determine whether Bloomage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bloomage with respect to the benefits of owning Bloomage Biotechnology security.